Abstract
Biotechnology Law ReportVol. 38, No. 6 As presented by Chris HolmanHZNP Medicines LLC v. Actavis Labs. UT, Inc. United States Court of Appeals of the Federal Circuit, 2019 940 F.3d 680Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:9 Dec 2019https://doi.org/10.1089/blr.2019.29149.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 38Issue 6Dec 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:HZNP Medicines LLC v. Actavis Labs. UT, Inc. United States Court of Appeals of the Federal Circuit, 2019 940 F.3d 680.Biotechnology Law Report.Dec 2019.412-426.http://doi.org/10.1089/blr.2019.29149.cmhPublished in Volume: 38 Issue 6: December 9, 2019PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
